Affiliation:
1. Federal University of Rio Grande do Sul, Brazil
Abstract
The introduction of oral phosphodiesterase type 5 inhibitor therapy in 1998 revolutionized the treatment of erectile dysfunction. Erectile dysfunction is the most common sexual problem in men. It often has a profound effect on intimate relationships and quality of life. The analysis of pharmaceuticals is an important part of the drug development process as well as for routine analysis and quality control of commercial formulations. Whereas the determination of sildenafil citrate, vardenafil and tadalafil are well documented by a variety of methods, there are few publications about the determination of udenafil, lodenafil carbonate, mirodenafil and avanafil. The paper presents a brief review of the action mechanism, adverse effects, pharmacokinetics and the most recent analytical methods that can determine drug concentration in biological matrices and pharmaceutical formulations of these four drugs.
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference69 articles.
1. Evaluation and treatment of erectile dysfunction;ALBERSEN M.;Med. Clin. North Am.,2011
2. Validated method for tadalafil analysis in pharmaceutical preparations by capillary electrophoresis;ALI I.;Chromatographia,2004
3. Future prospects in the treatment of erectile dysfunction: focus on avanafil;ALWAAL A.;Drug Des. Dev. Ther.,2011
4. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction;ANDERSSON K.E.;Pharmacol. Res.,2011
5. Endothelial dysfunction and erectile dysfunction in the aging man;AVERSA A.;Int. J. Urol.,2010
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献